Form 8-K - Current report:
SEC Accession No. 0001193125-24-165670
Filing Date
2024-06-21
Accepted
2024-06-21 16:12:31
Documents
14
Period of Report
2024-06-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d826313d8k.htm   iXBRL 8-K 52431
2 EX-10.1 d826313dex101.htm EX-10.1 73869
  Complete submission text file 0001193125-24-165670.txt   267802

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA orgo-20240620.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE orgo-20240620_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orgo-20240620_pre.xml EX-101.PRE 10816
18 EXTRACTED XBRL INSTANCE DOCUMENT d826313d8k_htm.xml XML 3535
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37906 | Film No.: 241060305
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)